The Joe Rogan ExperienceRick Perry & Hubbard on Joe Rogan: Why $100M on ibogaine
How veteran testimony drove Texas to fund $100M in ibogaine FDA trials; the drug claims to reset opioid and alcohol dependence in 48 to 72 hours.
CHAPTERS
- 0:02 – 4:57
Texas commits $100M to the Ibogaine Initiative after a last-minute legislative push
Bryan Hubbard recaps the whirlwind campaign in Texas to fund ibogaine drug development, culminating in an 11th-hour reversal. He confirms Texas will now fully fund the effort at $100M, framing it as the largest psychedelic research and medical development project to date.
- •Organizing 30 committed Texans to champion ibogaine as a public-health moonshot
- •Securing support from 181 of 188 Texas legislators during a five-and-a-half-month push
- •The initiative nearly failed in budget negotiations before a last-minute approval
- •Texas shifts from public-private concept to fully state-funded $100M commitment
- 4:57 – 6:52
How Dan Patrick was persuaded: veterans’ testimonies, science, and a spiritual case
Rogan asks what changed Lt. Gov. Dan Patrick’s mind. Hubbard explains that direct advocacy from veterans—especially Marcus and Morgan Luttrell—opened the door, after which the team presented ibogaine’s medical promise and transformative personal impact.
- •Dan Patrick initially skeptical and disengaged
- •Marcus and Morgan Luttrell share personal ibogaine outcomes and veterans’ needs
- •Argument emphasizes ending compulsive behavior and restoring agency
- •Spiritual framing: experiences often reinforce a sense of human divinity
- 6:52 – 8:55
Ibogaine 101: origins, history, and why it’s uniquely potent for addiction interruption
Hubbard defines ibogaine, its botanical and cultural roots in Gabon, and its decades of field evidence. He describes its distinct ability to interrupt physiological dependence across multiple substances and possibly compulsive behaviors.
- •Ibogaine is an alkaloid from the iboga shrub, long used in Bwiti traditions
- •1960s discovery of dramatic opioid withdrawal and craving interruption
- •Open-label evidence suggests effectiveness across opioids, alcohol, meth, cocaine, tobacco
- •Possible benefits for compulsions tied to dopamine-driven behaviors
- 8:55 – 12:33
Veterans, TBI, and neuroregeneration: Stanford findings and broader healing claims
The discussion shifts to special operations veterans seeking ibogaine in Mexico for TBI-related depression, anxiety, and suicidality. Hubbard highlights Stanford’s early findings suggesting neuroregenerative effects and shares additional anecdotal reports across neurological conditions.
- •2018 onward: Special Forces seek ibogaine for TBI symptoms and suicidality
- •Stanford research suggests unprecedented neuroregenerative potential
- •Anecdotal reports include MS, Lyme, Parkinson’s, and post-surgical brain recovery
- •Americans for Ibogaine founded to accelerate FDA-path development
- 12:33 – 14:35
Rick Perry’s personal motivation: Marcus Luttrell, suicide risk, and changing his worldview
Perry explains he didn’t enter politics to champion psychedelics; he was drawn in by witnessing Marcus Luttrell’s suffering and near-suicide. He details years of trying conventional treatments and how ibogaine ultimately cleared opioid addiction in a way other interventions couldn’t.
- •Marcus lived at the governor’s mansion while battling opioids and alcohol
- •Conventional rehab and treatment helped manage but didn’t resolve core issues
- •Ibogaine later removed opioid addiction completely for Marcus
- •Perry frames advocacy as a moral duty to veterans and families
- 14:35 – 24:11
From “tough on crime” to reform—and from ‘Just Say No’ to ibogaine advocacy
Perry draws parallels between his evolution on criminal justice reform and psychedelics. He argues anti-drug narratives were shaped by Nixon-era scheduling and decades of cultural messaging, despite ibogaine being non-addictive and non-recreational.
- •Texas criminal justice reform as proof conservatives can change policy with evidence
- •Nixon’s scheduling and war-on-drugs politics shaped public perceptions
- •Ibogaine is not addictive and has legitimate medical purpose
- •Legislative momentum spreading across multiple conservative states
- 24:11 – 28:47
Sponsor break and movement-building: Americans for Ibogaine scales nationwide
After an ad read, the conversation returns to organizational growth. Perry and Hubbard describe Americans for Ibogaine’s expanding ambassador network and the strategy of building credibility, partnerships, and state-by-state political momentum.
- •AFI began as a small board; now has ambassadors across the U.S.
- •Perry emphasizes resourcing travel and outreach to sustain momentum
- •Goal: make clinical trials undeniable to skeptics
- •Public advocacy framed as life-saving and evidence-driven
- 28:47 – 35:42
Why it works (and why it’s not ‘fun’): neuroplasticity windows, withdrawal interruption, and hard experiences
Perry cites research comparisons across psychedelics’ ‘critical periods’ and notes ibogaine’s unusually long neuroplasticity window. Hubbard stresses ibogaine’s intensity and side effects, arguing its unpleasantness underscores it isn’t recreational while still being transformative for severe cases.
- •Critical period comparison: ibogaine’s window described as ~90–120 days
- •Claims of opioid interruption in 48–72 hours; two-dose outcomes cited as even higher
- •Stanford imaging claims: addicted brain scans normalize rapidly post-ibogaine
- •Treatment can involve vomiting, paralysis-like immobility, and profound introspection
- 35:42 – 41:14
Stories across society: trauma survivors, first responders, moral injury, CTE, and pro sports
They share diverse case examples—from childhood sexual abuse recovery to first responders regaining careers, to moral injury relief, to athletes showing CTE-like symptoms. Rogan suggests connecting with the UFC, and they discuss head trauma in fighters and football players.
- •Trauma survivors report breakthroughs after other therapies failed
- •First responders and police report restored function and sobriety
- •Moral injury and suicidal ideation addressed in warfighters
- •CTE and concussion-related symptoms in NFL/NHL and potential relevance for UFC
- 41:14 – 45:58
Faith and psychedelics: Christian objections, scripture, and “A Christian’s Guide to Psychedelics”
Perry addresses conservative Christian resistance and introduces an upcoming book reframing psychedelics through scripture and personal testimony. Rogan and Hubbard add examples of psychedelic interpretations in religious scholarship, emphasizing how cultural stigma—not evidence—shaped modern views.
- •Conservative Christian communities often label psychedelics as ‘demonic’
- •Wendi Rees’ book aims to reconcile faith with psychedelic medicine
- •Discussion of Moses/burning bush and DMT-acacia hypothesis
- •Nixon-era demonization positioned as political suppression of movements
- 45:58 – 53:56
Spiritual famine, AI-era abundance, and psychedelics as social cohesion technology
Hubbard broadens the lens: he argues modern America faces a spiritual crisis exploited by institutional power. He links forthcoming AI-driven abundance to the need for a spiritual reawakening, claiming psychedelics can help societies mature enough to handle transformative technologies.
- •Claim: America is in ‘spiritual famine’ amid material wealth
- •Concern about government systems perpetuating misery and monetizing problems
- •AI could solve scarcity, but social cohesion is needed to avoid dystopian outcomes
- •Docuseries ‘Psychedelics &’ teased as a cultural catalyst
- 53:56 – 56:08
Curiosity, media narratives, and identity: why minds change (and why stereotypes persist)
Rogan, Perry, and Hubbard explore how dogma blocks curiosity and how identity-based opinions hinder growth. They detour into stereotypes (including Southern accents) and the role of media in manufacturing division, emphasizing direct human contact over broadcast narratives.
- •Rogan: ‘You are not your ideas’—change requires humility and evidence
- •Perry: personal evolution on reform and psychedelics as model for listeners
- •Discussion of Southern stereotypes and Rogan’s hookworm explanation
- •Hubbard: stopping TV news improved his view of the country and its people
- 56:08 – 1:33:21
Scientific partnerships and Perry’s own ibogaine treatment: brain scans, atrophy reversal, and CTE concerns
Perry reads a statement on a major collaboration with the Center for BrainHealth (UT Dallas) and partners to study ibogaine’s brain impact in veterans. He then recounts undergoing ibogaine himself for concussion-related anxiety/insomnia and describes striking changes in brain imaging, pivoting to Rogan’s concussion history and interest in treatment.
- •Center for BrainHealth partnership to study ‘who benefits, why, and duration’ over 18 months
- •Perry describes ibogaine-only protocol (declined 5-MeO-DMT)
- •Claims: prefrontal cortex activity increased and brain atrophy appeared to resolve
- •Rogan acknowledges many concussions and says he’d do ibogaine treatment
- 1:33:21 – 1:43:52
Multi-state coalition and global/tribal expansion: bills, votes, Gabon partnership, and Native sovereignty questions
Hubbard outlines a coordinated strategy to unite states behind a single FDA trial and lists legislative wins and active bills across the country. He also announces recognition by Gabon’s government and describes outreach to the Choctaw Nation and other tribes, prompting Rogan to ask whether tribal sovereignty could accelerate access.
- •Aspen convening of officials from 22 states to build an ‘unstoppable’ multi-state force
- •Specific legislative updates: TN, MO, OK, LA, KY, WV, MS (major margins cited)
- •Gabon names AFI an official partner for advancing iboga globally
- •Tribal discussions begin; Rogan asks about clinics/retreats and sovereignty logistics
- 1:43:52 – 1:57:53
Regulatory choke points and the presidential ask: scheduling, Right-to-Try, and a 3-year ‘moonshot’
They identify the DEA and federal bureaucracy as key obstacles, especially around Schedule I status and Right-to-Try interpretations. Hubbard lays out an explicit agenda for presidential action: rescheduling, directing agencies, and partnering with states to accelerate development.
- •DEA interpretation currently blocks Schedule I substances from federal Right-to-Try access
- •Call to reschedule ibogaine (to Schedule II/III) and align federal support
- •Proposal: accelerate through FDA phases with federal-state partnership within ~3 years
- •Rogan commits to helping the message reach the President
- 1:57:53 – 2:07:30
Kentucky origins and political grievance: town halls, trauma stories, and a sharp critique of Andy Beshear
Hubbard recounts Kentucky opioid-abatement town halls that became public grief forums and shares a story linking childhood sexual abuse, medical opioids, and incarceration. He then launches into a pointed political critique of Kentucky Gov. Andy Beshear’s record and Purdue Pharma ties, arguing it exemplifies institutional failure that ibogaine could help rectify.
- •Town halls revealed deep distrust in government’s ability to address the opioid crisis
- •Story of ‘Tamara’: abuse → surgeries → opioids → street purchase → jail
- •Argument: power responds to trauma with punishment rather than healing
- •Extended critique of Andy Beshear’s COVID policies and Purdue Pharma connections
- 2:07:30 – 2:14:29
Closing: a generational manifesto and a spiritual call to ‘bind up the brokenhearted’
As they wrap, Hubbard delivers a sweeping statement about America’s crises—opioids, economic dispossession, and war-related suicide—framing ibogaine as a humanitarian and spiritual emancipation project. Rogan thanks them and ends the episode after Hubbard’s poetic final appeal.
- •Claims: overdose, alcohol disease, and suicide deaths exceed historic war casualties
- •America’s institutions framed as deceitful and captured by corrupt incentives
- •Ibogaine mission positioned as restoring purpose, dignity, and spiritual identity
- •Final benediction-style close; Rogan thanks guests and signs off
